FDA Using Medicare Data Linked to NCI Databases to Look at Cancer Signals
This article was originally published in RPM Report
Executive Summary
FDA is looking at linking Medicare data to National Cancer Institute registries to enhance the information from medical claims data and gain a better understanding of disease-cancer and drug-cancer relationships. A familiar figure from FDA epidemiological work is keenly involved: safety officer David Graham.